Prevention of Hepatitis C Virus Infestion in Children with Haemophilia A and B and von Willebrand’s Disease

• References

• 1 Makris M, Preston FE, Triger DR. et al Hepatitis C antibody and chronic liver disease in haemophilia. Lancet 1990; i: 1117-1119
• 2 Noel L, Guerois C, Maisonneuve P. et al Antibodies to hepatitis C virus in haemophilia. Lancet 1989; ii: 550
• 3 Esteban JI, Esteban R, Viladomiu L. et al Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; ii: 294-297
• 4 Roggendorf M, Deinhardt F, Rasshofer R. et al Antibodies to hepatitis C virus. Lancet 1989; ii: 324-325
• 5 Heimburger N, Schwinn H, Gratz G. et al Faktor-VIII-Konzentrat, hochgereinigt und in Losung erhitzt. Drug Res 1981; 31: 619-622
• 6 Hilfenhaus J, Herrmann A, Mauler R, Prince AM. Inactivation of the AIDS-causing retrovirus and other human viruses in antihemophilic plasma protein preparations by pasteurisation. Vox Sang 1986; 50: 208
• 7 Hilfenhaus J, Weidmann E. Pasteurization as an efficient method to inactivate blood borne viruses in factor VIII concentrates. Drug Res 1986; 36: 621
• 8 Schimpf K, Mannucci PM, Kreuz W. et al Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions. N Engl J Med 1987; 316: 918-922
• 9 Mannucci PM, Colombo M. Revision of the protocol recommended for studies of safety from hepatitis of clotting factor concentrates. Thromb Haemostas 1989; 61: 532-534
• 10 Colvin BT. Prevention of hepatitis C virus infection in haemophiliacs. Lancet 1990; i: 1474